U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Les Laboratoires Blanchard - 06/24/2014
  1. Warning Letters


Les Laboratoires Blanchard

Les Laboratoires Blanchard

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993


JUN 24, 2014

Mr. Jean Blanchard
Co-owner and President
Les Laboratoires Blanchard
1552 King Ouest, Suite 200
Sherbrooke, Quebec J1J2C3

Dear Mr. Blanchard:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, CMS #249294, dated December 23, 2011. Based on our evaluation, it appears that your firm has addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




Steven D. Silverman
Office of Compliance
Center for Devices and
Radiological Health


Mr. Pierre L. Blanchard, Co-Owner
Les Laboratoires Blanchard
1552 King Ouest, Suite 200
Sherbrooke. Quebec J1J2C3

Back to Top